ELADYNOS
DEAD

Serial Number

97388239

Owner

Radius Health, Inc.

Attorney

Nicholas B. Hawkins

Filing Date

Apr 29, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ELADYNOS Trademark

Serial Number: 97388239

ELADYNOS is a trademark filed by Radius Health, Inc. on April 29, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Radius Health, Inc. (36 trademarks)

300 Technology Square, 5th Floor
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

April 29, 2022

Registration Date

Not Registered

Published for Opposition

December 13, 2022

Goods & Services

Pharmaceutical preparations for use in the treatment of bone diseases, connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, cancer, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-related disorders and conditions; Pharmaceutical preparations to treat wounds and trauma

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 16, 2026 MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 16, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 16, 2026 ABN6
ABANDONMENT - NO USE STATEMENT FILED
Mar 16, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 22, 2025 EXRA
SOU EXTENSION 5 GRANTED
Dec 22, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 22, 2025 AITU
SOU EXTENSION 5 FILED
Aug 1, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
Aug 1, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 6, 2025 EXRA
SOU EXTENSION 4 GRANTED
Feb 6, 2025 EX4G
SOU EXTENSION 4 FILED
Feb 5, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 5, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 5, 2024 EXRA
SOU EXTENSION 3 GRANTED
Aug 5, 2024 EX3G
SOU EXTENSION 3 FILED
Aug 5, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 5, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 3, 2024 EXRA
SOU EXTENSION 2 GRANTED
Feb 1, 2024 EX2G
SOU EXTENSION 2 FILED
Feb 1, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 1, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 1, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jul 30, 2023 EX1G
SOU EXTENSION 1 FILED
Jul 30, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 30, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 7, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 13, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 13, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 23, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 9, 2022 CNSA
ASSIGNED TO EXAMINER
Nov 7, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 4, 2022 NWOS
NEW APPLICATION ENTERED
May 3, 2022 NWAP